Skip to main content
Top
Published in: Diabetology & Metabolic Syndrome 1/2019

Open Access 01-12-2019 | Prediabetes | Research

Assessment of the relationship between serum uric acid and glucose levels in healthy, prediabetic and diabetic individuals

Authors: Tangigul Haque, Sadaqur Rahman, Shiful Islam, Noyan Hossain Molla, Nurshad Ali

Published in: Diabetology & Metabolic Syndrome | Issue 1/2019

Login to get access

Abstract

Background

In epidemiological studies, serum uric acid (SUA) has been shown to be associated with hypertension and cardiovascular disorders. However, limited studies have evaluated the relationship between SUA and glucose levels in healthy and diabetic individuals and their observed findings are inconsistent. This study aimed to examine the relationship between SUA and fasting blood glucose (FBG) levels among healthy, prediabetic and diabetic individuals in Bangladesh.

Methods

In total, 310 blood samples were collected from 215 male and 95 female subjects and analyzed for FBG, SUA, and lipid levels. All participants were categorized into four quartiles based on SUA concentrations. Diabetes and prediabetes were defined as FBG level ≥ 126 mg/dL and 100–125 mg/dL, respectively. The association between SUA and diabetes was evaluated by multinomial logistic regression analysis.

Results

The prediabetic and diabetic individuals had a lower mean level of SUA (338.2 ± 101.6 and 290.9 ± 98.2 µmol/L, respectively) compared to healthy (369.5 ± 110.9 µmol/L) individuals (p < 0.001). SUA was positively associated with BMI, TG and TC but negatively associated with FBG. The prevalence of diabetes was decreased with increasing concentration of SUA across the quartiles. In regression analysis, SUA levels were inversely associated with diabetes mellitus.

Conclusions

SUA levels were high in healthy individuals but declined in prediabetic and diabetic individuals with increasing FBG concentrations. A significant inverse association was observed between the levels of SUA and diabetes in Bangladeshi adults. Further studies are needed to examine the reliability of using SUA to predict diabetes.
Literature
1.
go back to reference Remedios C, Shah M, Bhasker AG, Lakdawala M. Hyperuricemia: a reality in the Indian obese. Obes Surg. 2012;22:945–8.CrossRef Remedios C, Shah M, Bhasker AG, Lakdawala M. Hyperuricemia: a reality in the Indian obese. Obes Surg. 2012;22:945–8.CrossRef
2.
go back to reference Glantzounis G, Tsimoyiannis E, Kappas A, Galaris D. Uric acid and oxidative stress. Curr Pharm Des. 2005;11:4145–51.CrossRef Glantzounis G, Tsimoyiannis E, Kappas A, Galaris D. Uric acid and oxidative stress. Curr Pharm Des. 2005;11:4145–51.CrossRef
3.
go back to reference Chen L, Zhu W, Chen Z, Dai H, Ren J, Chen J, et al. Relationship between hyperuricemia and metabolic syndrome. J Zhejiang Univ Sci B. 2007;8:593–8.CrossRef Chen L, Zhu W, Chen Z, Dai H, Ren J, Chen J, et al. Relationship between hyperuricemia and metabolic syndrome. J Zhejiang Univ Sci B. 2007;8:593–8.CrossRef
4.
go back to reference Ali N, Perveen R, Rahman S, Mahmood S, Rahman S, Islam S, et al. Prevalence of hyperuricemia and the relationship between serum uric acid and obesity: a study on Bangladeshi adults. PLoS ONE. 2018;13:e0206850.CrossRef Ali N, Perveen R, Rahman S, Mahmood S, Rahman S, Islam S, et al. Prevalence of hyperuricemia and the relationship between serum uric acid and obesity: a study on Bangladeshi adults. PLoS ONE. 2018;13:e0206850.CrossRef
5.
go back to reference Ali N, Rahman S, Islam S, Haque T, Molla NH, Sumon AH, et al. The relationship between serum uric acid and lipid profile in Bangladeshi adults. BMC Cardiovasc Disord. 2019;19:42.CrossRef Ali N, Rahman S, Islam S, Haque T, Molla NH, Sumon AH, et al. The relationship between serum uric acid and lipid profile in Bangladeshi adults. BMC Cardiovasc Disord. 2019;19:42.CrossRef
6.
go back to reference Wang S, Shu Z, Tao Q, Yu C, Zhan S, Li L. Uric acid and incident chronic kidney disease in a large health check-up population in Taiwan: uric acid and incident CKD. Nephrology. 2011;16:767–76.CrossRef Wang S, Shu Z, Tao Q, Yu C, Zhan S, Li L. Uric acid and incident chronic kidney disease in a large health check-up population in Taiwan: uric acid and incident CKD. Nephrology. 2011;16:767–76.CrossRef
7.
go back to reference Shankar A, Klein R, Klein BEK, Nieto FJ. The association between serum uric acid level and long-term incidence of hypertension: population-based cohort study. J Hum Hypertens. 2006;20:937.CrossRef Shankar A, Klein R, Klein BEK, Nieto FJ. The association between serum uric acid level and long-term incidence of hypertension: population-based cohort study. J Hum Hypertens. 2006;20:937.CrossRef
9.
go back to reference Feig DI, Kang D-H, Johnson RJ. Uric acid and cardiovascular risk. N Engl J Med. 2008;359:1811–21.CrossRef Feig DI, Kang D-H, Johnson RJ. Uric acid and cardiovascular risk. N Engl J Med. 2008;359:1811–21.CrossRef
10.
go back to reference Dehghan A, Van Hoek M, Sijbrands EJ, Hofman A, Witteman JC. High serum uric acid as a novel risk factor for type 2 diabetes. Diabetes Care. 2008;31:361–2.CrossRef Dehghan A, Van Hoek M, Sijbrands EJ, Hofman A, Witteman JC. High serum uric acid as a novel risk factor for type 2 diabetes. Diabetes Care. 2008;31:361–2.CrossRef
11.
go back to reference Chien K-L, Chen M-F, Hsu H-C, Chang W-T, Su T-C, Lee Y-T, et al. Plasma uric acid and the risk of type 2 diabetes in a Chinese community. Clin Chem. 2008;54:310–6.CrossRef Chien K-L, Chen M-F, Hsu H-C, Chang W-T, Su T-C, Lee Y-T, et al. Plasma uric acid and the risk of type 2 diabetes in a Chinese community. Clin Chem. 2008;54:310–6.CrossRef
12.
go back to reference Kramer CK, Von Mühlen D, Jassal SK, Barrett-Connor E. Serum uric acid levels improve prediction of incident type 2 diabetes in individuals with impaired fasting glucose: the Rancho Bernardo Study. Diabetes Care. 2009;32:1272–3.CrossRef Kramer CK, Von Mühlen D, Jassal SK, Barrett-Connor E. Serum uric acid levels improve prediction of incident type 2 diabetes in individuals with impaired fasting glucose: the Rancho Bernardo Study. Diabetes Care. 2009;32:1272–3.CrossRef
13.
go back to reference Kodama S, Saito K, Yachi Y, Asumi M, Sugawara A, Totsuka K, et al. Association between serum uric acid and development of type 2 diabetes. Diabetes Care. 2009;32:1737–42.CrossRef Kodama S, Saito K, Yachi Y, Asumi M, Sugawara A, Totsuka K, et al. Association between serum uric acid and development of type 2 diabetes. Diabetes Care. 2009;32:1737–42.CrossRef
14.
go back to reference Taniguchi Y, Hayashi T, Tsumura K, Endo G, Fujii S, Okada K. Serum uric acid and the risk for hypertension and Type 2 diabetes in Japanese men: the Osaka Health Survey. J Hypertens. 2001;19:1209–15.CrossRef Taniguchi Y, Hayashi T, Tsumura K, Endo G, Fujii S, Okada K. Serum uric acid and the risk for hypertension and Type 2 diabetes in Japanese men: the Osaka Health Survey. J Hypertens. 2001;19:1209–15.CrossRef
15.
go back to reference Modi AS, Sahi N. Serum uric acid levels in type 2 diabetes mellitus. Indian J Basic Appl Med Res. 2018;7:459–63. Modi AS, Sahi N. Serum uric acid levels in type 2 diabetes mellitus. Indian J Basic Appl Med Res. 2018;7:459–63.
17.
go back to reference Bonakdaran S, Kharaqani B. Association of serum uric acid and metabolic syndrome in type 2 diabetes. Curr Diabetes Rev. 2014;10:113–7.CrossRef Bonakdaran S, Kharaqani B. Association of serum uric acid and metabolic syndrome in type 2 diabetes. Curr Diabetes Rev. 2014;10:113–7.CrossRef
18.
go back to reference Oda E, Kawai R, Sukumaran V, Watanabe K. Uric acid is positively associated with metabolic syndrome but negatively associated with diabetes in Japanese men. Intern Med. 2009;48:1785–91.CrossRef Oda E, Kawai R, Sukumaran V, Watanabe K. Uric acid is positively associated with metabolic syndrome but negatively associated with diabetes in Japanese men. Intern Med. 2009;48:1785–91.CrossRef
19.
go back to reference Rabari K, Samadhiya A, Saha S, Sharma A, Mirza AA, Naithani M. A study to assess serum uric acid level and its association with glycemic parameters in individuals with prediabetes and diabetes mellitusin a North Indian tertiary care hospital. Yuva J Med Sci. 2018;4:12–8. Rabari K, Samadhiya A, Saha S, Sharma A, Mirza AA, Naithani M. A study to assess serum uric acid level and its association with glycemic parameters in individuals with prediabetes and diabetes mellitusin a North Indian tertiary care hospital. Yuva J Med Sci. 2018;4:12–8.
20.
go back to reference Nan H, Dong Y, Gao W, Tuomilehto J, Qiao Q. Diabetes associated with a low serum uric acid level in a general Chinese population. Diabetes Res Clin Pract. 2007;76:68–74.CrossRef Nan H, Dong Y, Gao W, Tuomilehto J, Qiao Q. Diabetes associated with a low serum uric acid level in a general Chinese population. Diabetes Res Clin Pract. 2007;76:68–74.CrossRef
21.
go back to reference Rodríguez G, Soriano LC, Choi HK. Impact of diabetes against the future risk of developing gout. Ann Rheum Dis. 2010;69:2090–4.CrossRef Rodríguez G, Soriano LC, Choi HK. Impact of diabetes against the future risk of developing gout. Ann Rheum Dis. 2010;69:2090–4.CrossRef
22.
go back to reference Pan A, Teng GG, Yuan J-M, Koh W-P. Bidirectional association between diabetes and gout: the Singapore Chinese Health Study. Sci Rep. 2016;6:25766.CrossRef Pan A, Teng GG, Yuan J-M, Koh W-P. Bidirectional association between diabetes and gout: the Singapore Chinese Health Study. Sci Rep. 2016;6:25766.CrossRef
23.
go back to reference van der Schaft N, Brahimaj A, Wen K-X, Franco OH, Dehghan A. The association between serum uric acid and the incidence of prediabetes and type 2 diabetes mellitus: the Rotterdam Study. PLoS ONE. 2017;12:e0179482.CrossRef van der Schaft N, Brahimaj A, Wen K-X, Franco OH, Dehghan A. The association between serum uric acid and the incidence of prediabetes and type 2 diabetes mellitus: the Rotterdam Study. PLoS ONE. 2017;12:e0179482.CrossRef
24.
go back to reference Pavani CH, Mohanty S, Dharwadkar AA. Hypouricemia in type 2 diabetes mellitus without nephropathy: a case control study. Int J Clin Biochem Res. 2018;5:201–5.CrossRef Pavani CH, Mohanty S, Dharwadkar AA. Hypouricemia in type 2 diabetes mellitus without nephropathy: a case control study. Int J Clin Biochem Res. 2018;5:201–5.CrossRef
25.
go back to reference Lipkowitz MS. Regulation of uric acid excretion by the kidney. Curr Rheumatol Rep. 2012;14:179–88.CrossRef Lipkowitz MS. Regulation of uric acid excretion by the kidney. Curr Rheumatol Rep. 2012;14:179–88.CrossRef
26.
go back to reference Barbieri L, Verdoia M, Schaffer A, Marino P, Suryapranata H, De Luca G, et al. Impact of sex on uric acid levels and its relationship with the extent of coronary artery disease: a single-centre study. Atherosclerosis. 2015;241:241–8.CrossRef Barbieri L, Verdoia M, Schaffer A, Marino P, Suryapranata H, De Luca G, et al. Impact of sex on uric acid levels and its relationship with the extent of coronary artery disease: a single-centre study. Atherosclerosis. 2015;241:241–8.CrossRef
27.
go back to reference Ali N, Mahmood S, Manirujjaman M, Perveen R, Al Nahid A, Ahmed S, et al. Hypertension prevalence and influence of basal metabolic rate on blood pressure among adult students in Bangladesh. BMC Public Health. 2017;18:58.CrossRef Ali N, Mahmood S, Manirujjaman M, Perveen R, Al Nahid A, Ahmed S, et al. Hypertension prevalence and influence of basal metabolic rate on blood pressure among adult students in Bangladesh. BMC Public Health. 2017;18:58.CrossRef
29.
go back to reference Sui X, Church TS, Meriwether RA, Lobelo F, Blair SN. Uric acid and the development of metabolic syndrome in women and men. Metabolism. 2008;57:845–52.CrossRef Sui X, Church TS, Meriwether RA, Lobelo F, Blair SN. Uric acid and the development of metabolic syndrome in women and men. Metabolism. 2008;57:845–52.CrossRef
30.
go back to reference You L, Liu A, Wuyun G, Wu H, Wang P. Prevalence of hyperuricemia and the relationship between serum uric acid and metabolic syndrome in the Asian Mongolian area. J Atheroscler Thromb. 2014;21:355–65.CrossRef You L, Liu A, Wuyun G, Wu H, Wang P. Prevalence of hyperuricemia and the relationship between serum uric acid and metabolic syndrome in the Asian Mongolian area. J Atheroscler Thromb. 2014;21:355–65.CrossRef
31.
go back to reference Program (NCEP) ES of TTR of TNCE. Expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA. 2001;285:2486–97.CrossRef Program (NCEP) ES of TTR of TNCE. Expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA. 2001;285:2486–97.CrossRef
32.
go back to reference Strasak A, Ruttmann E, Brant L, Kelleher C, Klenk J, Concin H, et al. Serum uric acid and risk of cardiovascular mortality: a prospective long-term study of 83 683 Austrian men. Clin Chem. 2008;54:273–84.CrossRef Strasak A, Ruttmann E, Brant L, Kelleher C, Klenk J, Concin H, et al. Serum uric acid and risk of cardiovascular mortality: a prospective long-term study of 83 683 Austrian men. Clin Chem. 2008;54:273–84.CrossRef
33.
go back to reference Tuomilehto J, Zimmet P, Wolf E, Taylor R, Ram P, King H. Plasma uric acid level and its association with diabetes mellitus and some biologic parameters in a biracial population of Fiji. Am J Epidemiol. 1988;127:321–36.CrossRef Tuomilehto J, Zimmet P, Wolf E, Taylor R, Ram P, King H. Plasma uric acid level and its association with diabetes mellitus and some biologic parameters in a biracial population of Fiji. Am J Epidemiol. 1988;127:321–36.CrossRef
34.
go back to reference Herman JB, Medalie JH, Goldbourt U. Diabetes, prediabetes and uricaemia. Diabetologia. 1976;12:47–52.CrossRef Herman JB, Medalie JH, Goldbourt U. Diabetes, prediabetes and uricaemia. Diabetologia. 1976;12:47–52.CrossRef
35.
go back to reference So A, Thorens B. Uric acid transport and disease. J Clin Invest. 2010;120:1791–9.CrossRef So A, Thorens B. Uric acid transport and disease. J Clin Invest. 2010;120:1791–9.CrossRef
36.
go back to reference Mount DB, Kwon CY, Zandi-Nejad K. Renal urate transport. Rheum Dis Clin. 2006;32:313–31.CrossRef Mount DB, Kwon CY, Zandi-Nejad K. Renal urate transport. Rheum Dis Clin. 2006;32:313–31.CrossRef
37.
go back to reference Maesaka JK, Fishbane S. Regulation of renal urate excretion: a critical review. Am J Kidney Dis. 1998;32:917–33.CrossRef Maesaka JK, Fishbane S. Regulation of renal urate excretion: a critical review. Am J Kidney Dis. 1998;32:917–33.CrossRef
38.
go back to reference Levinson DJ, Sorensen LB. Renal handling of uric acid in normal and gouty subject: evidence for a 4-component system. Ann Rheum Dis. 1980;39:173–9.CrossRef Levinson DJ, Sorensen LB. Renal handling of uric acid in normal and gouty subject: evidence for a 4-component system. Ann Rheum Dis. 1980;39:173–9.CrossRef
39.
go back to reference Anzai N, Kanai Y, Endou H. New insights into renal transport of urate. Curr Opin Rheumatol. 2007;19:151–7.CrossRef Anzai N, Kanai Y, Endou H. New insights into renal transport of urate. Curr Opin Rheumatol. 2007;19:151–7.CrossRef
40.
go back to reference Mather A, Pollock C. Glucose handling by the kidney. Kidney Int. 2011;79:S1–6.CrossRef Mather A, Pollock C. Glucose handling by the kidney. Kidney Int. 2011;79:S1–6.CrossRef
41.
go back to reference Augustin R, Carayannopoulos MO, Dowd LO, Phay JE, Moley JF, Moley KH. Identification and characterization of human glucose transporter-like protein-9 (GLUT9) alternative splicing alters trafficking. J Biol Chem. 2004;279:16229–36.CrossRef Augustin R, Carayannopoulos MO, Dowd LO, Phay JE, Moley JF, Moley KH. Identification and characterization of human glucose transporter-like protein-9 (GLUT9) alternative splicing alters trafficking. J Biol Chem. 2004;279:16229–36.CrossRef
42.
go back to reference Maritim AC, Sanders RA, Watkins JB. Diabetes, oxidative stress, and antioxidants: a review. J Biochem Mol Toxicol. 2003;17:24–38.CrossRef Maritim AC, Sanders RA, Watkins JB. Diabetes, oxidative stress, and antioxidants: a review. J Biochem Mol Toxicol. 2003;17:24–38.CrossRef
43.
go back to reference Palanduz S, Ademoğlu E, Gökkuşu C, Tamer S. Plasma antioxidants and type 2 diabetes mellitus. Res Commun Mol Pathol Pharmacol. 2001;109:309–18.PubMed Palanduz S, Ademoğlu E, Gökkuşu C, Tamer S. Plasma antioxidants and type 2 diabetes mellitus. Res Commun Mol Pathol Pharmacol. 2001;109:309–18.PubMed
44.
go back to reference Memısoğullari R, Taysı S, Bakan E, Capoglu I. Antioxidant status and lipid peroxidation in type II diabetes mellitus. Cell Biochem Funct. 2003;21:291–6.CrossRef Memısoğullari R, Taysı S, Bakan E, Capoglu I. Antioxidant status and lipid peroxidation in type II diabetes mellitus. Cell Biochem Funct. 2003;21:291–6.CrossRef
45.
go back to reference Mahmood IH. Serum uric acid concentration in patients with type 2 diabetes mellitus during diet or glibenclamide therapy. Pak J Med Sci. 2007;23:361. Mahmood IH. Serum uric acid concentration in patients with type 2 diabetes mellitus during diet or glibenclamide therapy. Pak J Med Sci. 2007;23:361.
Metadata
Title
Assessment of the relationship between serum uric acid and glucose levels in healthy, prediabetic and diabetic individuals
Authors
Tangigul Haque
Sadaqur Rahman
Shiful Islam
Noyan Hossain Molla
Nurshad Ali
Publication date
01-12-2019
Publisher
BioMed Central
Keyword
Prediabetes
Published in
Diabetology & Metabolic Syndrome / Issue 1/2019
Electronic ISSN: 1758-5996
DOI
https://doi.org/10.1186/s13098-019-0446-6

Other articles of this Issue 1/2019

Diabetology & Metabolic Syndrome 1/2019 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine